Cronos Group Inc. (TSX:CRON)
Canada · Delayed Price · Currency is CAD | Market Cap | 1.36B +27.4% |
| Revenue (ttm) | 184.36M +19.0% |
| Net Income | 50.28M |
| EPS | 0.13 |
| Shares Out | 382.89M |
| PE Ratio | 27.07 |
| Forward PE | 36.79 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 60,523 |
| Average Volume | 185,184 |
| Open | 3.500 |
| Previous Close | 3.520 |
| Day's Range | 3.500 - 3.610 |
| 52-Week Range | 2.270 - 4.660 |
| Beta | 1.18 |
| RSI | 47.05 |
| Earnings Date | Feb 27, 2026 |
About Cronos Group
Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brand names. The company is based in Stayner, Canada. [Read more]
Full Company ProfileNews
3 Top Canadian Marijuana Stocks To Buy Sell Or Hold In 2026
What is it about the cannabis industry that keeps investors searching for top marijuana stocks to buy? Cannabis started as one of the first waves of peace, love, and rebellion towards many cultural in...
Cronos Group Inc. to Hold 2025 Fourth Quarter and Full-Year Earnings Conference Call on February 26, 2026
TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2025 fourth quarter and full-year earnings conference call on Thursday...
3 Canadian Marijuana Stocks Today's Stock Market That Could Soon Run
The cannabis industry is in another pivotal time where consistent changes are being made. Laws and regulations have been passed across the country that have aided in the further development of industr...
Cronos Group Launches Premium Lord Jones® Brand in Israel, Advancing Borderless Product Strategy
TORONTO, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON; TSX: CRON) (“Cronos” or the “Company”), a leading global cannabinoid company, today announced the launch of its Lord Jones® ...
International Vector Equity Portfolio Buys 10,939 Shares of Cronos Group Inc (CRON)
International Vector Equity Portfolio Buys 10,939 Shares of Cronos Group Inc (CRON)
Park Edge Advisors, LLC Sells 976 Shares of Cronos Group Inc (CRON)
Park Edge Advisors, LLC Sells 976 Shares of Cronos Group Inc (CRON)
International Vector Equity Portfolio Buys 5 Shares of Cronos Group Inc (CRON)
International Vector Equity Portfolio Buys 5 Shares of Cronos Group Inc (CRON)
How to play cannabis stocks in 2026
President Trump's executive order to reschedule marijuana is one of the many things cannabis investors will be watching in 2026. AdvisorShares portfolio manager Dan Ahrens, who manages the firm's Pure...
3 Marijuana Stocks For Investors To Make Money In 2026
Finding the best marijuana stocks in the stock market today may be easier than you think. At one time, it was a simple task to determine which cannabis companies were better to invest in. Even with th...
Marijuana industry taking fight against Wall Street blockades straight to Trump
Bankers have argued that Pot Inc.'s far-bigger prospective business – recreational use that would include the smoking of joints and ingesting high-inducing gummies – wasn't specifically addressed by t...
Best Canadian Cannabis Stocks to Watch Entering 2026
The cannabis industry continues to evolve as investors look toward 2026 with renewed optimism. Canadian cannabis companies remain at the center of global expansion. They benefit from strong medical pr...
Cronos: A Standout Balance Sheet Among Its Peers
Cronos Group operates in a highly competitive industry but has a marked advantage over its peers owing to its vastly superior balance sheet. This superiority is a result of a 2019 investment by Altria...
Trump Is Warming to Cannabis, but Investors Aren't Impressed
Stocks took a surprise tumble after the White House moved to reclassify marijuana as a less dangerous drug.
2 Marijuana Stocks To Watch For Better Investing In 2026
The cannabis industry continues evolving into a bigger and more regulated global market. Legalization trends are expanding across the United States and international regions. This growth fuels long-te...
3 Marijuana Stocks To Watch In 2026
The cannabis industry is entering another critical growth phase, positioning 2026 as a potentially pivotal year. Particularly for long-term investors looking to make a profit with marijuana stocks. Af...
Marijuana Stocks To Watch After The Holidays
In 2026, the impact of cannabis rescheduling is expected to be far more visible in marijuana stock performance. Much more than in the initial announcement of cannabis becoming a Class 3 substance. Whi...
3 Top Marijuana Stocks After Cannabis Gets Rescheduled
Donald Trump's recent executive order moving cannabis off Schedule I marks a pivotal moment for the U.S. cannabis sector. While the order does not legalize marijuana at the federal level, rescheduling...
Inside the dealmaking that pushed Trump to reclassify pot, expand access
President Donald Trump's marijuana reclassification executive order followed a yearlong push by cannabis executives, billionaire allies and political operatives combining donations, lobbying and targe...
After Trump's move to reclassify cannabis, here's what Wall Street is thinking
Analysts are now focused on the when the change will actually happen, as the cannabis industry waits for tax relief and expanded research opportunities.
Trump signs executive order to reschedule cannabis. Here's what's next
Trump's executive order shifts cannabis from Schedule I to Schedule III, and launches a Medicare pilot program for CBD products. Brandon Gomez unpacks what's next, the hurdles ahead and what shifted t...
Trump just legalized marijuana nationwide — here's why potheads are rejoicing
As On The Money has been reporting since April, our famously drug-and-drink-averse president has been inching ever closer to making marijuana significantly less criminal in the eyes of the federal gov...
Trump sparks market shock with MAJOR marijuana move
Rep. Greg Steube, R-Fla., joins ‘Mornings with Maria' to discuss cutting healthcare costs, the fight over Obamacare subsidies and shutdown risks, President Donald Trump's marijuana order and the GOP's...
Former WH drug policy advisor: Mass commercialization and promotion of marijuana isn't a good thing
Kevin Sabet, Smart Approaches to Marijuana CEO, former White House drug policy advisor and ‘One Nation Under Influence' author, joins 'Squawk Box' to discuss President Trump's executive order to recla...
Why US banks are still wary of cannabis despite Trump's policy shift
President Donald Trump's move to relax federal marijuana regulations has been welcomed by the US cannabis industry, but it has not changed the sector's most persistent challenge. Access to mainstream ...
How Trump's marijuana reclassification could impact medical research
Scotts Miracle-Gro CEO James Hagedorn discusses President Donald Trump signing an executive order to reclassify marijuana on ‘The Claman Countdown.' #fox #media #breakingnews #us #usa #new #news #brea...